Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $619.42 billion, total revenue of $161.32 billion and a weighted average PE ratio of 50.20.
Market Cap
619.42B
Revenue
161.32B
Profits
12.34B
PE Ratio
50.20
Profit Margin
7.65%
Dividend Yield
0.24%
51 Stocks
No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
---|---|---|---|---|---|---|
1 | TMO | Thermo Fisher Scientific Inc. | 160.72B | -2.09% | 2,225,273 | 42.90B |
2 | DHR | Danaher Corporation | 142.26B | -2.96% | 3,505,509 | 23.82B |
3 | IDXX | IDEXX Laboratories, Inc. | 42.85B | -0.10% | 164,990 | 3.93B |
4 | A | Agilent Technologies, Inc. | 34.20B | -2.34% | 1,057,988 | 6.63B |
5 | IQV | IQVIA Holdings Inc. | 27.74B | -1.51% | 888,197 | 15.50B |
6 | MTD | Mettler-Toledo International Inc. | 24.97B | -1.84% | 139,496 | 3.83B |
7 | NTRA | Natera, Inc. | 21.60B | -1.41% | 511,874 | 1.83B |
8 | LH | Labcorp Holdings Inc. | 20.95B | 0.28% | 525,045 | 13.18B |
9 | DGX | Quest Diagnostics Incorporated | 18.84B | 0.42% | 909,797 | 10.16B |
10 | WAT | Waters Corporation | 18.30B | -12.88% | 2,691,274 | 2.98B |
11 | ILMN | Illumina, Inc. | 15.63B | -0.54% | 1,086,400 | 4.34B |
12 | ICLR | ICON Public Limited Company | 11.90B | -0.54% | 787,882 | 8.19B |
13 | RVTY | Revvity, Inc. | 11.65B | -2.65% | 681,759 | 2.77B |
14 | QGEN | Qiagen N.V. | 10.46B | 0.37% | 1,053,077 | 2.00B |
15 | EXAS | Exact Sciences Corporation | 10.26B | 4.78% | 1,521,631 | 2.83B |
16 | MEDP | Medpace Holdings, Inc. | 9.24B | -0.58% | 235,758 | 2.16B |
17 | CRL | Charles River Laboratories International, Inc. | 7.77B | -0.79% | 372,048 | 4.02B |
18 | GH | Guardant Health, Inc. | 6.18B | -0.66% | 962,648 | 774.00M |
19 | RDNT | RadNet, Inc. | 4.23B | 1.59% | 386,173 | 1.87B |
20 | SHC | Sotera Health Company | 3.30B | -1.53% | 400,460 | 1.11B |
21 | WGS | GeneDx Holdings Corp. | 2.35B | -0.04% | 354,714 | 330.14M |
22 | TWST | Twist Bioscience Corporation | 2.27B | -0.32% | 903,805 | 347.68M |
23 | VCYT | Veracyte, Inc. | 2.09B | -1.44% | 265,450 | 463.39M |
24 | GRAL | GRAIL, Inc. | 1.45B | -1.35% | 539,437 | 130.71M |
25 | NEOG | Neogen Corporation | 1.14B | -2.23% | 2,009,644 | 906.00M |
26 | CDNA | CareDx, Inc | 1.12B | -0.12% | 591,043 | 346.42M |
27 | OPK | OPKO Health, Inc. | 1.06B | -1.11% | 953,647 | 689.41M |
28 | NEO | NeoGenomics, Inc. | 924.03M | -1.10% | 789,600 | 672.36M |
29 | FLGT | Fulgent Genetics, Inc. | 584.21M | -0.42% | 148,275 | 292.45M |
30 | PSNL | Personalis, Inc. | 565.28M | 0.47% | 678,185 | 85.69M |
31 | CSTL | Castle Biosciences, Inc. | 560.41M | -1.27% | 119,344 | 347.08M |
32 | MYGN | Myriad Genetics, Inc. | 480.24M | -2.43% | 474,489 | 831.30M |
33 | XGN | Exagen Inc. | 154.55M | 1.14% | 461,224 | 56.72M |
34 | MDXH | MDxHealth SA | 107.90M | - | 39,342 | 94.51M |
35 | PRE | Prenetics Global Limited | 105.31M | 2.41% | 28,004 | 41.52M |
36 | FONR | FONAR Corporation | 102.12M | 2.33% | 52,413 | 103.02M |
37 | IMDX | Insight Molecular Diagnostics Inc. | 80.65M | -1.40% | 21,419 | 3.84M |
38 | NOTV | Inotiv, Inc. | 66.47M | -3.73% | 184,005 | 480.40M |
39 | BNR | Burning Rock Biotech Limited | 49.73M | 9.53% | 32,044 | 72.11M |
40 | BDSX | Biodesix, Inc. | 45.32M | 0.19% | 487,049 | 74.46M |
41 | PRPO | Precipio, Inc. | 21.99M | -6.90% | 18,474 | 20.03M |
42 | PRPH | ProPhase Labs, Inc. | 17.24M | -2.03% | 353,775 | 5.85M |
43 | ADVB | Advanced Biomed Inc. | 17.20M | 5.71% | 573,406 | - |
44 | BIAF | bioAffinity Technologies, Inc. | 7.96M | -5.70% | 868,801 | 8.81M |
45 | STRR | Star Equity Holdings, Inc. | 6.29M | -2.00% | 13,293 | 57.17M |
46 | MYNZ | Mainz Biomed N.V. | 6.19M | -6.25% | 119,323 | 893.99K |
47 | NDRA | ENDRA Life Sciences Inc. | 6.06M | 1.36% | 77,413 | - |
48 | XWEL | XWELL, Inc. | 5.18M | 1.03% | 6,958 | 32.19M |
49 | CHEK | Check-Cap Ltd. | 4.62M | 0.51% | 13,066 | - |
50 | ISPC | iSpecimen Inc. | 2.74M | 4.76% | 321,830 | 8.06M |
51 | APDN | Applied DNA Sciences, Inc. | 2.70M | 0.97% | 29,435 | 3.79M |